ArticleDisease markers2020

Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer.

Bide Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.